Day: October 15, 2025

Company intends to collaborate with government initiatives, Long COVID patient organizations, and major healthcare providers to expedite development of TVGN 489 In recognition of the high volume of patient inquiries, Tevogen has established a dedicated communication channel for Long COVID updates at longCOVID@tevogen.comWARREN, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) — WARREN, N.J., Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today issued an update regarding growing public interest in its investigational precision T cell therapy, TVGN 489, under development for COVID-19 and Long COVID. “We’re deeply moved by the number of Long COVID patients expressing interest in TVGN 489,” said Dr. Ryan Saadi, Chief Executive Officer of Tevogen Bio. “This level of engagement underscores the urgent need for effective and...

MONTEBELLO, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, announced the grand opening of six new model homes at Metro Heights, a master-planned community in Montebello, California. These model homes, located in the Skyview and Silverstone collections, are now open for touring at 425 Mariposa Way in Montebello. “We are excited to unveil these stunning new model homes at Metro Heights,” said Brad Hare, Division President of Toll Brothers in Southern California. “Our thoughtfully designed homes offer luxurious living spaces, breathtaking views, and access to unparalleled resort-style amenities, making Metro Heights an ideal place for families to call home.”Metro Heights is a gated community nestled in the hills of Montebello, offering one- and two-story single-family...

Nasdaq Hearing Cancellation and Continued Listing FOSTER CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California based late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, had previously announced that it had filed an application to appeal the delisting notification previously received from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) and request a hearing before a Nasdaq Hearings Panel to review the Staff’s delisting determination. The Company today announced that it had received a letter from Nasdaq on October 14, 2025, notifying Apollomics the Staff had determined that the Company is in compliance with Nasdaq’s continued...

Nasdaq Hearing Cancellation and Continued Listing FOSTER CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California based late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, had previously announced that it had filed an application to appeal the delisting notification previously received from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) and request a hearing before a Nasdaq Hearings Panel to review the Staff’s delisting determination. The Company today announced that it had received a letter from Nasdaq on October 14, 2025, notifying Apollomics the Staff had determined that the Company is in compliance with Nasdaq’s continued...

CLEVELAND, Oct. 15, 2025 (GLOBE NEWSWIRE) — CBIZ, Inc. (NYSE: CBZ) (the “Company”), a leading national professional services advisor, will announce its financial results for the third-quarter and year-to-date periods ended September 30, 2025, after markets close on Wednesday, October 29, 2025. A conference call to discuss the Company’s financial results will be hosted by CBIZ President and Chief Executive Officer Jerry Grisko and Chief Financial Officer Brad Lakhia at 5 p.m. (ET) on Wednesday, October 29, 2025. The conference call will be webcast live on the investor relations page of the CBIZ website at https://cbiz.gcs-web.com/investor-overview. An archived replay of the webcast will be available following the conclusion of the call. Investors can register at https://dpregister.com/sreg/10203902/1002b28f89e to receive the dial-in...